Hyperbaric intra-thecal ropivacaine - a comparison with hyperbaric bupivacaine with respect to extent and duration of motor block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN36749569

Enrollment

Registered

2006-09-29

Start date

2005-05-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Anaesthesia Surgery Anaesthesia

Interventions

40 patients undergoing spinal anaethesia would be recruited to our study and randomised to receive equal hyperbaric doses of either 0.5% bupivacaine in 8% glucose solution or 0.5% ropivacaine in 8% gl

Eligibility

Inclusion criteria

Inclusion criteria: 1. Elective surgery 2. Patient and surgery appropriate for spinal anaesthesia 3. ASA grade 18 yrs 5. Non-pregnant 6. No known sensitivities to amide class of local anaesthetics 7. Not currently or recently (<3 months) recruited to other clinical trials

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026